Brief: G1 Therapeutics Reports Q2 Loss Per Share $0.92

G1 Therapeutics

03/08/2022 11:55

Aug 3 (Reuters) - G1 Therapeutics Inc  GTHX.O :
    * G1 THERAPEUTICS PROVIDES SECOND QUARTER 2022 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
    * Q2 REVENUE $10.6 MILLION
    * Q2 REVENUE VIEW $9.1 MILLION -- REFINITIV IBES DATA
    * Q2 LOSS PER SHARE $0.92
    * Q2 EARNINGS PER SHARE VIEW $-1.02 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX3tLtMn 
Further company coverage:  GTHX.O 

 ((Reuters.Briefs@thomsonreuters.com;))